Trial Profile
A Study to Evaluate High Eradication Rate of Vonoprazan-based triple therapy Compared to Esomeprazole (EO) -based therapy in Patients Infected with H. pylori who are Resistant to Clarithromycin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole
- Indications Helicobacter pylori infections
- Focus Adverse reactions; Therapeutic Use
- 20 Jun 2016 New trial record
- 24 May 2016 Results presented at the Digestive Disease Week 2016.